news

PRESS RELEASE

Puurs 8 october 2013Ā - Solar encapsulant specialist NovoPolymers attracted a new investor Capital-E, completing a repositioning of the company in the current dynamic photovoltaic market. New investor Capital-E led the round, and was joined by existing investors Gimv, Capricorn Cleantech Fund, Federale Participatie- en Investeringsmaatschappij (SFPI-FPIM). The additional funding is used to support the company in accelerating, its breakthrough key developments and global presence.

"Our new technologies are keeping pace with the high requirements of module innovation. Product line extensions are geared to support a higher efficiency at lower cost," said Koen Hasaers CEO of NovoPolymers. "Relying on our robust expertise, NovoPolymers targets new high end encapsulant solutions, and is in the final stage of testing glass-glass tailored encapsulants for launch in Q1 2014. In our technology pipeline both niche and mass applications are supported such as new thin film encapsulants, and EVA alternatives."

"NovoPolymers has opted to use the current industry downturn to focus on new R&D tracks to strengthen its encapsulant portfolio with breakthrough innovative products aiming at increasing the power output of a solar module. Moreover, this is complemented with a major initiative of redirecting and controlling global supply through local manufacturing by judiciously chosen subcontractors. This lean strategy based on a solid foundation of R&D capabilities has convinced us to participate in this exciting venture." said Sofie Baeten, Partner of Capital-E.

About Novopolymers

NovoPolymers NV markets globally high tech NovoVellumĀ® encapsulants based on proprietary technology. Its solutions are applied in crystalline silicon and thin film technology. The development capability is enabled by distinctive research institutes with major credentials in solar technology by means of joint projects. Besides key innovation NovoPolymers thrives on quality in product and service of which an UL listing, and ISO9001:2008 accreditation are testimonies.